IBDEI0PI ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12506,2)
 ;;=^87863
 ;;^UTILITY(U,$J,358.3,12507,0)
 ;;=282.5^^70^765^7
 ;;^UTILITY(U,$J,358.3,12507,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12507,1,1,0)
 ;;=1^282.5
 ;;^UTILITY(U,$J,358.3,12507,1,8,0)
 ;;=8^Sickle-Cell Trait
 ;;^UTILITY(U,$J,358.3,12507,2)
 ;;=^110419
 ;;^UTILITY(U,$J,358.3,12508,0)
 ;;=282.63^^70^765^8
 ;;^UTILITY(U,$J,358.3,12508,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12508,1,1,0)
 ;;=1^282.63
 ;;^UTILITY(U,$J,358.3,12508,1,8,0)
 ;;=8^Sickle-Cell/Hb-C Disease
 ;;^UTILITY(U,$J,358.3,12508,2)
 ;;=^267983
 ;;^UTILITY(U,$J,358.3,12509,0)
 ;;=282.41^^70^765^10
 ;;^UTILITY(U,$J,358.3,12509,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12509,1,1,0)
 ;;=1^282.41
 ;;^UTILITY(U,$J,358.3,12509,1,8,0)
 ;;=8^Thalassemias
 ;;^UTILITY(U,$J,358.3,12509,2)
 ;;=^329908
 ;;^UTILITY(U,$J,358.3,12510,0)
 ;;=282.49^^70^765^9
 ;;^UTILITY(U,$J,358.3,12510,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12510,1,1,0)
 ;;=1^282.49
 ;;^UTILITY(U,$J,358.3,12510,1,8,0)
 ;;=8^Thalassemia NEC
 ;;^UTILITY(U,$J,358.3,12510,2)
 ;;=^329910
 ;;^UTILITY(U,$J,358.3,12511,0)
 ;;=288.09^^70^765^1
 ;;^UTILITY(U,$J,358.3,12511,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12511,1,1,0)
 ;;=1^288.09
 ;;^UTILITY(U,$J,358.3,12511,1,8,0)
 ;;=8^Agranulocytosis
 ;;^UTILITY(U,$J,358.3,12511,2)
 ;;=^334042
 ;;^UTILITY(U,$J,358.3,12512,0)
 ;;=289.4^^70^765^4
 ;;^UTILITY(U,$J,358.3,12512,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12512,1,1,0)
 ;;=1^289.4
 ;;^UTILITY(U,$J,358.3,12512,1,8,0)
 ;;=8^Hypersplenism
 ;;^UTILITY(U,$J,358.3,12512,2)
 ;;=^60330
 ;;^UTILITY(U,$J,358.3,12513,0)
 ;;=188.9^^70^766^1
 ;;^UTILITY(U,$J,358.3,12513,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12513,1,1,0)
 ;;=1^188.9
 ;;^UTILITY(U,$J,358.3,12513,1,8,0)
 ;;=8^Bladder
 ;;^UTILITY(U,$J,358.3,12513,2)
 ;;=^267253
 ;;^UTILITY(U,$J,358.3,12514,0)
 ;;=233.7^^70^766^2
 ;;^UTILITY(U,$J,358.3,12514,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12514,1,1,0)
 ;;=1^233.7
 ;;^UTILITY(U,$J,358.3,12514,1,8,0)
 ;;=8^Ca In Situ Bladder
 ;;^UTILITY(U,$J,358.3,12514,2)
 ;;=^267742
 ;;^UTILITY(U,$J,358.3,12515,0)
 ;;=185.^^70^766^5
 ;;^UTILITY(U,$J,358.3,12515,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12515,1,1,0)
 ;;=1^185.
 ;;^UTILITY(U,$J,358.3,12515,1,8,0)
 ;;=8^Prostate
 ;;^UTILITY(U,$J,358.3,12515,2)
 ;;=^99481
 ;;^UTILITY(U,$J,358.3,12516,0)
 ;;=189.0^^70^766^3
 ;;^UTILITY(U,$J,358.3,12516,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12516,1,1,0)
 ;;=1^189.0
 ;;^UTILITY(U,$J,358.3,12516,1,8,0)
 ;;=8^Kidney
 ;;^UTILITY(U,$J,358.3,12516,2)
 ;;=^73523
 ;;^UTILITY(U,$J,358.3,12517,0)
 ;;=189.1^^70^766^6
 ;;^UTILITY(U,$J,358.3,12517,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12517,1,1,0)
 ;;=1^189.1
 ;;^UTILITY(U,$J,358.3,12517,1,8,0)
 ;;=8^Renal Pelvis
 ;;^UTILITY(U,$J,358.3,12517,2)
 ;;=^267264
 ;;^UTILITY(U,$J,358.3,12518,0)
 ;;=189.2^^70^766^8
 ;;^UTILITY(U,$J,358.3,12518,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12518,1,1,0)
 ;;=1^189.2
 ;;^UTILITY(U,$J,358.3,12518,1,8,0)
 ;;=8^Ureter
 ;;^UTILITY(U,$J,358.3,12518,2)
 ;;=^267265
 ;;^UTILITY(U,$J,358.3,12519,0)
 ;;=189.3^^70^766^9
 ;;^UTILITY(U,$J,358.3,12519,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12519,1,1,0)
 ;;=1^189.3
 ;;^UTILITY(U,$J,358.3,12519,1,8,0)
 ;;=8^Urethra
 ;;^UTILITY(U,$J,358.3,12519,2)
 ;;=^267266
 ;;^UTILITY(U,$J,358.3,12520,0)
 ;;=186.9^^70^766^7
 ;;^UTILITY(U,$J,358.3,12520,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12520,1,1,0)
 ;;=1^186.9
 ;;^UTILITY(U,$J,358.3,12520,1,8,0)
 ;;=8^Testis
 ;;^UTILITY(U,$J,358.3,12520,2)
 ;;=^267242
 ;;^UTILITY(U,$J,358.3,12521,0)
 ;;=187.4^^70^766^4
